Natalie A. LaFranzo

Natalie first joined Cofactor Genomics in 2013, with a PhD in Chemistry from Washington University in St. Louis. Natalie has developed customized experimental solutions for both DNA and RNA applications at Cofactor, as well as launched and supported diagnostic reference standards as a part of Horizon Discovery’s Diagnostics Division. Natalie now supports Cofactor’s clinical collaborations, outreach efforts, and marketing strategy as the VP of Market Development, with the goal of expanding the utility of Predictive Immune Modeling for cancer biomarker discovery.